Skip to main content

Advertisement

Log in

Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

An Erratum to this article was published on 27 March 2017

Abstract

Background

Studies have reported that breast cancer patients have limited understanding about the oncologic outcomes following contralateral prophylactic mastectomy (CPM). We hypothesized that an in-visit decision aid (DA) would be associated with higher patient knowledge about the anticipated short and long term outcomes of CPM.

Methods

We piloted a DA which used the SCOPED: (Situation, Choices, Objectives, People, Evaluation and Decision) framework. Knowledge, dichotomized as “low” (≤3 correct) versus “high” (≥4 correct), was assessed immediately after the visit by a 5 item survey. There were 97 DA patients (response rate 62.2 %) and 114 usual care (UC) patients (response rate 71.3 %).

Results

Patient demographic factors were similar between the two groups. Twenty-one (21.7 %) patients in the DA group underwent CPM compared with 18 (15.8 %) in the UC group (p = 0.22). Mean and median knowledge levels were significantly higher in the DA group compared with the UC group for patients of all ages, tumor stage, race, family history, anxiety levels, worry about CBC, and surgery type. Eighty-six (78.9 %) of UC versus 35 (37.9 %) DA patients had low knowledge. Of patients who underwent CPM, 15 (83.3 %) in the UC cohort versus 5 (25.0 %) of DA patients had “low” knowledge.

Conclusions

Knowledge was higher in the DA group. The UC group had approximately three times the number of patients of the DA group who were at risk for making a poorly informed decision to have CPM. Future studies should assess the impact of increased knowledge on overall CPM rates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. King TA, Sakr R, Patil S, Gurevich I, Stempel M, Sampson M, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. J Clin Oncol. 2011;29(16):2158–64. doi:10.1200/JCO.2010.29.4041

    Article  PubMed  Google Scholar 

  2. Yao K, Stewart AK, Winchester DJ, Winchester DP. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007. Ann Surg Oncol. 2010;17(10):2554–62. doi:10.1245/s10434-010-1091-3

    Article  PubMed  Google Scholar 

  3. Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, et al. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol. 2009;27(9):1362–7. doi:10.1200/JCO.2008.20.1681

    Article  PubMed  Google Scholar 

  4. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9. doi:10.1200/JCO.2007.12.3141

    Article  PubMed  Google Scholar 

  5. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27(25):4082–8. doi:10.1200/JCO.2008.19.4225

    Article  PubMed  PubMed Central  Google Scholar 

  6. Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16(6):1597–605. doi:10.1245/s10434-009-0362-3

    Article  PubMed  Google Scholar 

  7. Wang F, Amara D, Peled AW, Sbitany H, Foster RD, Ewing CA, et al. Negative genetic testing does not deter contralateral prophylactic mastectomy in younger patients with greater family histories of breast cancer. Ann Surg Oncol. 2015;22(10):3338–45. doi:10.1245/s10434-015-4745-3

    Article  PubMed  Google Scholar 

  8. Hawley ST JR, Morrow M, Katz SJ. Correlates of contralateral prophylactic mastectomy in a population based sample. J Clin Oncol. 2011;29: 6010.

    Article  Google Scholar 

  9. Rosenberg SM, Tracy MS, Meyer ME, Sepucha K, Gelber S, Hirshfield-Bartek J, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey. Ann Intern Med. 2013;159(6):373–81. doi:10.7326/0003-4819-159-6-201309170-00003

    Article  PubMed  PubMed Central  Google Scholar 

  10. Soran A, Ibrahim A, Kanbour M, McGuire K, Balci FL, Polat AK, et al. Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer. Am J Clin Oncol. 2015;38(2):179–83. doi:10.1097/COC.0b013e318292f8a7

    Article  PubMed  Google Scholar 

  11. Han E, Johnson N, Glissmeyer M, Wagie T, Carey B, DelaMelena T, et al. Increasing incidence of bilateral mastectomies: the patient perspective. Am J Surg. 2011;201(5):615–8. doi:10.1016/j.amjsurg.2011.01.018

    Article  PubMed  Google Scholar 

  12. Covelli AM, Baxter NN, Fitch MI, McCready DR, Wright FC. ‘Taking control of cancer’: understanding women’s choice for mastectomy. Ann Surg Oncol. 2015;22(2):383–91. doi:10.1245/s10434-014-4033-7

    Article  PubMed  Google Scholar 

  13. Fagerlin A, Lakhani I, Lantz PM, Janz NK, Morrow M, Schwartz K, et al. An informed decision? Breast cancer patients and their knowledge about treatment. Patient Educ Counsel. 2006;64(1-3):303–12. doi:10.1016/j.pec.2006.03.010

    Article  Google Scholar 

  14. Abbott A, Rueth N, Pappas-Varco S, Kuntz K, Kerr E, Tuttle T. Perceptions of contralateral breast cancer: an overestimation of risk. Ann Surg Oncol. 2011;18(11):3129–36. doi:10.1245/s10434-011-1914-x

    Article  PubMed  Google Scholar 

  15. Portschy PR, Kuntz KM, Tuttle TM. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis. J Natl Cancer Inst. 2014;106(8). doi:10.1093/jnci/dju160.

    Article  PubMed  Google Scholar 

  16. Kruper L, Kauffmann RM, Smith DD, Nelson RA. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias. Ann Surg Oncol. 2014;21(11):3448–56. doi:10.1245/s10434-014-3930-0

    Article  PubMed  Google Scholar 

  17. Lostumbo L, Carbine N, Wallace J, Ezzo J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev. 2004(4):CD002748. doi:10.1002/14651858.CD002748.pub2

    Google Scholar 

  18. Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, et al. Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery. BMC Med Inform Decision Making. 2012;12:51. doi:10.1186/1472-6947-12-51

    Article  Google Scholar 

  19. Belkora JK, Loth MK, Volz S, Rugo HS. Implementing decision and communication aids to facilitate patient-centered care in breast cancer: a case study. Patient Educ Counsel. 2009;77(3): 360–8. doi:10.1016/j.pec.2009.09.012

    Article  Google Scholar 

  20. Belkora J. 2016. www.scoped.com.

  21. Whelan T, Levine M, Willan A, Gafni A, Sanders K, Mirsky D, et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA. 2004;292(4):435–41. doi:10.1001/jama.292.4.435

    Article  CAS  PubMed  Google Scholar 

  22. Goel V, Sawka CA, Thiel EC, Gort EH, O’Connor AM. Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Med Decision Making. 2001;21(1):1–6

    Article  CAS  Google Scholar 

  23. Street RL, Jr., Voigt B, Geyer C, Jr., Manning T, Swanson GP. Increasing patient involvement in choosing treatment for early breast cancer. Cancer. 1995;76(11):2275–85

    Article  PubMed  Google Scholar 

  24. Frost MH, Schaid DJ, Sellers TA, Slezak JM, Arnold PG, Woods JE, et al. Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA. 2000;284(3):319–24

    Article  CAS  PubMed  Google Scholar 

  25. Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, et al. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006;24(9):1350–6. doi:10.1200/JCO.2005.01.9901

    Article  PubMed  Google Scholar 

  26. Musiello T, Bornhammar E, Saunders C. Breast surgeons’ perceptions and attitudes towards contralateral prophylactic mastectomy. ANZ J Surg. 2013;83(7–8):527–32. doi:10.1111/j.1445-2197.2012.06209.x

    Article  PubMed  Google Scholar 

  27. Collins ED, Moore CP, Clay KF, Kearing SA, O’Connor AM, Llewellyn-Thomas HA, et al. Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol.2009;27(4):519–25. doi:10.1200/JCO.2008.16.6215

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katharine Yao MD.

Ethics declarations

DISCLOSURES

The authors have no disclosures to support.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1245/s10434-017-5850-2.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 32 kb)

Supplementary material 2 (DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yao, K., Belkora, J., Bedrosian, I. et al. Impact of an In-visit Decision Aid on Patient Knowledge about Contralateral Prophylactic Mastectomy: A Pilot Study. Ann Surg Oncol 24, 91–99 (2017). https://doi.org/10.1245/s10434-016-5556-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5556-x

Keywords

Navigation